[Delirium in the 'young' covid-19 patient (65 years): preliminary clinical indications]

Autor:	DI GIACOMO E., COLMEGNA F., SANTORELLI M., PESSINA R., D'AMICO E., MARCATILI M., DAKANALIS A., PAVONE F., FAGIOLINI A., CLERICI Massimo.
Přispěvatelé:	DI GIACOMO, E, Colmegna, F, Santorelli, M, Pessina, R, D'Amico, E, Marcatili, M, Dakanalis, A, Pavone, F, Fagiolini, A, Clerici, M
Rok vydání:	2021
Předmět:	Pregnancy Addiction COVID-19 Delirium Humans Drug Interactions Heart disease Immunocompromission Middle Aged Diabete Cancer COVID-19 Drug Treatment
Zdroj:	Rivista di psichiatria. 56(2)
ISSN:	2038-2502
Popis:	Delirium is a phenomenon classified within neuro-cognitive disorders in the DSM-5. It has several etiologies and it is often lethal. This contribute aims at analyzing clinical characteristics and diagnostic possibilities of delirium in patients affected by covid-19. Furthermore, some preliminary recommendations on the use of psychopharmacological treatment of delirium and their interactions with main drugs used to treat covid-19 are given, with a special attention to comorbidities like in immunocompromised patients, in those affected by diabetes and cancer, in pregnant women or in addicted clients.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c418d7d1cac90e8038ebca400ebd7c37 https://pubmed.ncbi.nlm.nih.gov/33899829 Zobrazit plný text záznamu